Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewscoronavirus

India makes COVID-19 treatment drug Remdesivir 'freely exportable'

Until now, the Government of India used to allow restricted export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) – a drug that is used in COVID-19 treatment.

February 24, 2022 / 08:45 PM IST
Remdesivir is an injectable antiviral drug produced by Gilead Sciences Inc. It is the first drug to have received approval from the USFDA in October 2020, making it the first medicine for treating COVID-19 infections.

Remdesivir is an injectable antiviral drug produced by Gilead Sciences Inc. It is the first drug to have received approval from the USFDA in October 2020, making it the first medicine for treating COVID-19 infections.

The Director General of Foreign Trade (DGFT) announced on February 24 that it has made Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API), and Intra-Venous Immunoglobulin (IVIG) as ‘freely’ exportable, effective immediately.

The announcement comes at a time the COVID-19 situation in the country is relatively under control with declining daily coronavirus cases and limited hospitalisations.

Until now, the Government of India used to allow restricted export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) – a drug that is used in COVID-19 treatment.

ICMR says Remdesivir 'not a life-saving drug', calls for safe and rational usage